Anon. Gagelmann N, Badbaran A, Salit RB, et al. Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation. Blood. 2023;141(23):2901-2911. Blood. 2024;143(18):1879. Google ScholarPubMedLog in or register to post comments